Adjuvant Therapy for Rectal Cancer

por Krishnamurthi, Smitha S., Seo, Yuji, Kinsella, Timothy J.
Publicado em 2007

The Impact of Delayed Chemotherapy on Its Completion and Survival Outcomes in Stage II Colon Cancer Patients

por Xu, Fang, Rimm, Alfred A., Fu, Pingfu, Krishnamurthi, Smitha S., Cooper, Gregory S.
Publicado em 2014

Pancreatic metastases to the colon: an unusual cause of colonic obstruction

por Park, Deborah Yae-jung, Krishnamurthi, Smitha, Chahal, Prabhleen, Downs-Kelly, Erinn, Morris-Stiff, Gareth
Publicado no BMJ Case Rep (2019)

Understanding Multilevel Factors Related to Urban Community Trust in Healthcare and Research

por Webb Hooper, Monica, Mitchell, Charlene, Marshall, Vanessa J., Cheatham, Chesley, Austin, Kristina, Sanders, Kimberly, Krishnamurthi, Smitha, Grafton, Lena L.
Publicado no Int J Environ Res Public Health (2019)

Videoconference Intervention for Distance Caregivers of Patients With Cancer: A Randomized Controlled Trial

por Douglas, Sara L., Mazanec, Polly, Lipson, Amy R., Day, Kim, Blackstone, Eric, Bajor, David L., Saltzman, Joel, Krishnamurthi, Smitha
Publicado no JCO Oncol Pract (2021)

A pilot study of a low glycemic load diet in patients with stage I-III colorectal cancer

por Treasure, Michelle, Thomas, Alicia, Ganocy, Stephen, Hong, Augustine, Krishnamurthi, Smitha S., Bajor, David L., Berger, Nathan A., Meropol, Neal J.
Publicado no J Gastrointest Oncol (2021)

A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma

por Fountzilas, Christos, Gupta, Medhavi, Lee, Sunyoung, Krishnamurthi, Smitha, Estfan, Bassam, Wang, Katy, Attwood, Kristopher, Wilton, John, Bies, Robert, Bshara, Wiam, Iyer, Renuka
Publicado no Br J Cancer (2020)

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors

por Brell, Joanna M., Krishnamurthi, Smitha S., Rath, Linda, Bokar, Joseph A., Savvides, Panayiotis, Gibbons, Joseph, Cooney, Matthew M., Meropol, Neal J., Ivy, Percy, Dowlati, Afshin
Publicado em 2012

Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles

por Sanborn, Sharon L., Cooney, Matthew M., Dowlati, Afshin, Brell, Joanna M., Krishnamurthi, Smitha, Gibbons, Joseph, Bokar, Joseph A., Nock, Charles, Ness, Anne, Remick, Scot C.
Publicado em 2008

Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers

por Dowlati, Afshin, Posey, James, Ramanathan, Ramesh K., Rath, Linda, Fu, Pingfu, Chak, Amitabh, Krishnamurthi, Smitha, Brell, Joanna, Ingalls, Stephen, Hoppel, Charles L., Ivy, Percy, Remick, Scot C.
Publicado no Cancer Chemother Pharmacol (2009)

A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic cancer

por Sohal, Davendra, Krishnamurthi, Smitha, Tohme, Rita, Gu, Xiaorong, Lindner, Daniel, Landowski, Terry H, Pink, John, Radivoyevitch, Tomas, Fada, Sherry, Lee, Zhenghong, Shepard, Dale, Khorana, Alok, Saunthararajah, Yogen
Publicado no Am J Cancer Res (2020)

A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma

por Brell, Joanna M., Krishnamurthi, Smitha S., Javle, Milind, Saltzman, Joel, Wollner, Ira, Pelley, Robert, Dowlati, Afshin, Kantharaj, Belagodu N., Schluchter, Mark D., Rath, Linda, Ivy, S. Percy, Remick, Scot C.
Publicado em 2008

A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors

por Nock, Charles J., Brell, Joanna M., Bokar, Joseph A., Cooney, Matthew M., Cooper, Brenda, Gibbons, Joseph, Krishnamurthi, Smitha, Manda, Sudhir, Savvides, Panayiotis, Remick, Scot C., Ivy, Percy, Dowlati, Afshin
Publicado em 2009

A phase I study of MK-5108, an oral aurora A kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tum...

por Amin, Manik, Minton, Susan E., LoRusso, Patricia M., Krishnamurthi, Smitha S., Pickett, Cheryl A., Lunceford, Jared, Hille, Darcy, Mauro, David, Stein, Mark N., Wang-Gillam, Andrea, Trull, Lauren, Lockhart, A. Craig
Publicado no Invest New Drugs (2015)

Phase II Study of Dasatinib (BMS-354825) in Patients With Metastatic Adenocarcinoma of the Pancreas

por Chee, Cheng Ean, Krishnamurthi, Smitha, Nock, Charles J., Meropol, Neal J., Gibbons, Joseph, Fu, PingFu, Bokar, Joseph, Teston, Lois, O'Brien, Timothy, Gudena, Vinay, Reese, Amy, Bergman, Mark, Saltzman, Joel, Wright, John J., Dowlati, Afshin, Brell, Joanna
Publicado em 2013

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine

por Krishnamurthi, Smitha S., Brell, Joanna M., Hoppel, Charles L., Egorin, Merrill J., Weaver, Karen C., Li, Xiaolin, Ingalls, Stephen T., Zuhowski, Eleanor G., Schluchter, Mark D., Dowlati, Afshin, Cooney, Matthew M., Gibbons, Joseph, Overmoyer, Beth A., Ivy, S. Percy, Remick, Scot C.
Publicado no Cancer Chemother Pharmacol (2008)

PHASE I CLINICAL TRIAL OF TEMOZOLOMIDE AND METHOXYAMINE (TRC-102), AN INHIBITOR OF BASE EXCISION REPAIR, IN PATIENTS WITH ADVANCED SOLID TUMORS

por Eads, Jennifer R., Krishnamurthi, Smitha S., Saltzman, Joel, Bokar, Joseph A., Savvides, Panos, Meropol, Neal J., Gibbons, Joseph, Koon, Henry, Sharma, Neelesh, Rogers, Lisa, Pink, John J., Xu, Yan, Beumer, Jan H., Riendeau, John, Fu, Pingfu, Gerson, Stanton L., Dowlati, Afshin
Publicado no Invest New Drugs (2020)

Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update

por Sohal, Davendra P.S., Kennedy, Erin B., Khorana, Alok, Copur, Mehmet S., Crane, Christopher H., Garrido-Laguna, Ignacio, Krishnamurthi, Smitha, Moravek, Cassadie, O’Reilly, Eileen M., Philip, Philip A., Ramanathan, Ramesh K., Ruggiero, Joseph T., Shah, Manish A., Urba, Susan, Uronis, Hope E., Lau, Michelle W., Laheru, Daniel
Publicado no J Clin Oncol (2018)

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

por Dizon, Don S., Krilov, Lada, Cohen, Ezra, Gangadhar, Tara, Ganz, Patricia A., Hensing, Thomas A., Hunger, Stephen, Krishnamurthi, Smitha S., Lassman, Andrew B., Markham, Merry Jennifer, Mayer, Erica, Neuss, Michael, Pal, Sumanta Kumar, Richardson, Lisa C., Schilsky, Richard, Schwartz, Gary K., Spriggs, David R., Villalona-Calero, Miguel Angel, Villani, Gina, Masters, Gregory
Publicado no J Clin Oncol (2016)

5-fluorouracil enhances the anti-tumor activity of the glutaminase inhibitor CB-839 against PIK3CA-mutant colorectal cancers

por Zhao, Yiqing, Feng, Xiujing, Chen, Yicheng, Selfridge, J. Eva, Gorityala, Shashank, Du, Zhanwen, Wang, Janet M., Hao, Yujun, Cioffi, Gino, Conlon, Ronald A., Barnholtz-Sloan, Jill S., Saltzman, Joel, Krishnamurthi, Smitha S., Vinayak, Shaveta, Veigl, Martina, Xu, Yan, Bajor, David L., Markowitz, Sanford D., Meropol, Neal J., Eads, Jennifer R., Wang, Zhenghe
Publicado no Cancer Res (2020)